Two German companies are at the forefront in the global race for a COVID-19 vaccine. But the potential of top German research could be used much more effectively, especially with the right level of investment.
Powered by Versicherungsvergleich
Latest News
- News24.com | Uganda's Museveni on track for sixth term as president
- News24.com | UN peacekeeper killed in Central African Republic
- Africa: Africa's Great Green Wall Aims for Fresh Growth Spurt After Sluggish Start
- Mesut Özil to Fenerbahce: A perfect fit?
- Luka Jovic returns to Frankfurt: Why do Bundesliga strikers struggle abroad?
- Bundesliga: Teuchert atones as Union Berlin late show sends them fourth
- Computer chip shortage disrupts global car production
- EU launches Year of Rail campaign amid drop in passenger numbers
- Opinion: Don't shut down the economy!
- WHO team in China: Searching for coronavirus' birthplace
- Computer chip shortage disrupts global car production
- Uganda election: Bobi Wine says military raids home
- What do you like about winter?
- Donald Trump supporters flock to niche social media sites
- Donald Trump's manipulative language
- Nature-based childhood helps people and the planet
- Nord Stream 2: Germany says construction can continue
- EU launches Year of Rail campaign amid drop in passenger numbers
- Open Skies: Russia starts withdrawing from defense pact
- Germany's ruling CDU set to elect new leader
- New partners for nature conservation in Peru's Andes
- Dutch government resigns over child benefits scandal
- British conductor Simon Rattle applies for German citizenship
- Mining tycoon Steinmetz on trial over Guinea bribes
- Mesut Özil to Fenerbahce: A perfect fit?